15 мая 2024 г. · Novo Nordisk owner buys majority stake in Austrian life science tools company · Novo A/S · Novo Nordisk A/S · Catalent Inc.

25 мар. 2024 г. · Denmark's Novo Nordisk said on Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen ...

25 мар. 2024 г. · Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up to 1.025 billion Euros, including an upfront payment and additional ...

Novo Nordisk has agreed to acquire Inversago for up to 1.075 billion US dollars in cash if certain development and commercial milestones are achieved.

5 февр. 2024 г. · Novo Holdings is to buy the New Jersey-based pharmaceutical firm Catalent, and then immediately sell three of its sites for $11bn in US and ...

8 февр. 2024 г. · Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5bn on an enterprise value basis.

8 нояб. 2024 г. · Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme · Bagsværd, Denmark ...

5 февр. 2024 г. · Shares of Catalent soar on news Novo Holdings, the majority owner of Novo Nordisk, is acquiring the syringe maker for $16.5 billion in cash.

3 нояб. 2024 г. · Catalent was recently acquired by Novo Holdings for $16.5 billion. This deal is slated to close later in 2024.

Acquisition history · Xellia (Acq 2013) · Ziylo (Acq 2018) · Corvidia Therapeutics (Acq 2020) · Emisphere Technologies (Acq 2020) · Dicerna Pharmaceuticals (Acq 2021) ... Team Novo Nordisk · Novo Nordisk Foundation · Novo Holdings A/S · Bagsværd